$BURU NUBURU Chairman Alessandro Zamboni Highlights $93.1M

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
37
$BURU NUBURU Chairman Alessandro Zamboni Highlights $93.1M Tekne Program Portfolio And $200M+ Potential Reactivation Opportunities Following Acquisition Of 70% Stake

Enlarged group enters Q4 with approximately $93.1 million in Tekne program value, more than $200 million in management-estimated reactivation opportunities, 185 personnel across three Italian facilities, and June 30 stockholders’ equity of $10.1 million — above NYSE American equity thresholds

NUBURU, Inc. (NYSE:BURU), the next-generation dual-use Defense & Security integrated platform company, today issued the following letter from Alessandro Zamboni, Executive Chairman and Co-Chief Executive Officer:

Dear Fellow Shareholders,

On October 15, NUBURU closed the acquisition of a 70% controlling interest in Tekne S.p.A. ("Tekne", materially expanding our operating industrial platform. On the same day, we filed a Form S-3 for the resale of shares related to our previously disclosed July offering. Following those announcements, I want to clarify the filing’s purpose, explain the industrial value Tekne brings and set out our priorities for financing and execution.

The October 15 Form S-3 and existing conversion rights

The October 15 Form S-3 is not a new capital raise. It was filed to register the resale of up to 20 million common shares issued or issuable upon conversion of the Series B preferred stock sold in our July public offering. Proceeds from that offering funded repayment of approximately $16.75 million of principal obligations under the December 2025 debenture and Lyocon acquisition notes. The filing itself issues no shares and raises no capital. It was made to satisfy previously disclosed registration obligations; it does not create new conversion rights.

The industrial scale Tekne brings to NUBURU

NUBURU today is a different company than it was ninety days ago. With Tekne, we own an established industrial business: approximately 185 personnel, three Italian facilities in Ortona, Poggiofiorito and Guastalla, a manufacturing history dating to 1990, and active customers across defense, civil protection, public safety and industrial markets. Tekne’s electronic-warfare and special-vehicle engineering now sits alongside Lyocon’s laser and photonics expertise and Orbit’s operational-resilience software. Together, these businesses provide revenue, production capacity and customer relationships from which to scale.

Tekne gives us the production and systems-integration base to move our technology toward customer deployment and to pursue opportunities across Italy, the United States, NATO and allied markets, subject to qualification and applicable approvals. Our mandate is direct: integrate Tekne into NUBURU’s group processes, strengthen financial and operational controls, align procurement, production and commercial execution, and make successful configurations repeatable, with the aim of extending equipment sales through software, maintenance, upgrades and lifecycle support. New integrated mission packages remain subject to technical qualification and customer acceptance.

A $93.1 million program base — and more than $200 million behind it

Tekne’s September 14 production schedule carried approximately $93.1 million (€80.6 million) of remaining program value, as reported in our October 15 announcement. This preliminary, unaudited measure covers 100% of Tekne and includes items subject to options, frameworks or activation requirements; it is not closing-date signed backlog or a revenue forecast. Beyond that recorded portfolio, management estimates more than $200 million in potential program value from the reactivation of selected defense-vehicle and mobility programs, including previously withdrawn procurement procedures and terminated supply contracts. We believe completion of the acquisition strengthens the basis for pursuing these opportunities. This separate estimate is excluded from the $93.1 million portfolio. The opportunities are not current awards and remain subject to the relevant authorities’ decisions and definitive contractual arrangements. Our focus is conversion into deliveries, customer acceptance, recognized revenue and cash.

NYSE American equity compliance update

Our Form 10-Q/A reported June 30, 2026 stockholders’ equity of $10,130,320, above the $2 million and $4 million thresholds under Sections 1003(a)(i) and 1003(a)(ii), respectively. We believe our reported equity meets those numerical requirements. We have submitted our quarterly update and supporting financial information to NYSE American, requesting confirmation of compliance with those equity requirements and conclusion of the related plan monitoring. The Exchange’s confirmation remains pending, and the compliance-plan period runs through October 29, 2026. We will update shareholders promptly upon the Exchange’s determination.

Financing execution and growth

Scaling an industrial defense business requires working capital: materials, components, production labor and inventory often require payment before delivery, acceptance and collection. Growth also requires investment in capacity, people and product qualification. Our financing strategy is to fund execution around executable customer programs. We are working with local banking partners and debt providers to structure working-capital and growth funding around production milestones and cash collection. Potential sources include receivables and inventory financing (on and off-balance sheet), equipment leasing, customer advances, debt and equity, subject to eligibility, credit approval and agreed terms. Completing an acquisition and financing the growth of the business it creates are two different requirements, and we intend to approach both with discipline. 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Class Action: Critical Investor Alert

Updated Category News Views 27

An Investor's Wake-Up Call: Beta Bionics Lawsuit Folks, if you've got skin in the game with Beta Bionics (NASDAQ: BBNX), there's a storm on the horizon. We're talking big legal guns out and aimed at Beta Bionics with that class action suit looming. If you sunk some serious dough between July 30, 2025, and February 24, 2026, it's time to shake up and assess your losses....

Continue Reading
Mahomes Faces Pressure to Ditch AIRSHARE After Tragedy

Updated Category News Views 40

Patrick Mahomes and the AIRSHARE Dilemma When the air turns turbulent, even the lucky stars often tremble. Kansas City Chiefs’ star quarterback, Patrick Mahomes, finds himself smack in the eye of such a storm. With a name as illustrious as his, the links to AIRSHARE, a private jet provider caught in the crosshairs of tragedy, create more than just a PR hiccup—they...

Continue Reading
Salus Scientific Pioneers Safety at TCT 2026

Updated Category News Views 10

Revolutionizing Occupational Safety in Healthcare Radiation exposure in the medical field: the dull, ominous toll it takes on healthcare professionals, often cloaked in acceptance as a mere occupational hazard. But here's Salus Scientific crashing into the party at TCT 2026 like a seasoned rockstar, demanding we stop accepting the dangers of fluoroscopy-guided procedures...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Civista Welcomes Healthcare Leader to Boost Growth

Updated Category News Views 103

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Solenis Appoints Brendy Lange to Lead Americas Growth

Updated Category News Views 6

New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 0

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 44

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 4

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading

Top 5 Most Recently Viewed Articles

MannKind Corporation: Innovations in Chronic Disease Management

Updated Category News Views 151

MannKind Corporation's Upcoming Conference Presentation MannKind Corporation (Nasdaq: MNKD) is poised to make a significant impact at the forthcoming Jefferies London Healthcare Conference, scheduled for Wednesday. The presentation will feature insights from Michael Castagna, the Chief Executive Officer, along with Chris Prentiss, the Chief Financial Officer. This...

Continue Reading
Greene County Bancorp Achieves Honorable Recognition in Banking

Updated Category News Views 160

Greene County Bancorp Earns Prestigious Recognition Greene County Bancorp, Inc. (NASDAQ: GCBC), has been recognized for its exemplary performance in the banking sector. This acknowledgment comes from Piper Sandler’s Class of 2025 Small-Cap All Stars, shining a spotlight on the best-performing banks in the competitive small-cap market. Greene County Bancorp was honored...

Continue Reading
Market Rally: Dow Surges as Investor Optimism Grows

Updated Category News Views 131

U.S. Stock Market Soars with Optimism The recent market activity reflects a significant uptick in investor sentiment, highlighting a change in the economic climate. The CNN Money Fear and Greed Index indicated a notable improvement, remaining in the "Greed" zone, which typically suggests a bullish perspective among investors. Dow Jones Index Records Major Gains On an...

Continue Reading
Innovative AI Research in Breast Cancer Detection by iCAD

Updated Category News Views 190

Innovative AI Research in Breast Cancer Detection by iCAD NASHUA, N.H. — iCAD, Inc. (NASDAQ: ICAD) has emerged as a pioneer in the field of cancer detection as they recently announced acceptance of four significant AI-driven research abstracts for presentation at the upcoming San Antonio Breast Cancer Symposium (SABCS). This event, a focal point for medical...

Continue Reading
Industrial AI Agents Tackle Capacity Gaps in 2026

Updated Category News Views 16

AI Agents Filling Industrial Workforce Gaps Industrial players are feeling the heat. On one hand, they face a workforce trailing behind demand, losing 41% of the workday to manual drudgery, and on the other, they’re grappling with an aging workforce retiring in droves. But here comes the knight in silicon armor: agentic digital workers. These AI-powered agents are...

Continue Reading